NCT02578706View on ClinicalTrials.gov

Targeting Platelets in Chronic HIV Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
HIV-1 Infection
Interventions
DRUG

Clopidogrel

Clopidogrel 75mg

DRUG

Aspirin

81 mg

DRUG

Placebo

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02578706 - Targeting Platelets in Chronic HIV Infection | Biotech Hunter | Biotech Hunter